Get Support Insurance Verification And Prior Authorization Form

is indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.

® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.

() is approved in Canada for the treatment of osteoporosis in men and postmenopausal females. it is given as an injection every 6 months and significantly reduces fracture risk.

All requests for (), () require a prior authorization and will be screened for medical necessity and appropriateness using the criteria listed below.

2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage should be administered by a healthcare professional. The recommended dose of is 60 mg administered as a single subcutaneous injection once every 6 months. Administer via subcutaneous injection in the upper arm, the upper thigh, or the abdomen.

First Coast Service Options-Jurisdiction N (MAC B) requires a prior authorization and step edit. Analysis includes Amgen Assist® insurance verification data for ® prospective patients only from 11/2021 to 4/2022. The co-pay may depend on coverage of additional insurance plan.

If you have questions about ® () and would like to speak to a representative, please call 1-877-4- (877-477-6542).

Insurance verification is related to the process of creating and filing medical claims and obtaining payment for patient services, while prior authorization is about obtaining prior authorization for services.